In this report we describe the transfer of chronic relapsing experimental allergic encephalomyelitis (EAE) with in vitro-stimulated lymph node cells (LNC) from SJL/J mice immunized with human myelin proteolipid protein (PLP). No additional immune enhancing procedures were applied in the transfer recipients. Clinical and histological EAE was transferred with 10-30 × 106 LNC to 27/28 mice. The LNC proliferated in vitro to PLP, but not to myelin basic protein (MBP), and induced delayed-type hypersensitivity. Enrichment for lymphoblasts by Ficoll centrifugation was essential for the disease development. The clinical course usually showed an early episode of acute paralytic illness, followed by chronic relapsing disease, and resembled the transfer of EAE using MBP-specific cells, both clinically and histologically.
|Original language||English (US)|
|Number of pages||9|
|Journal||Journal of Neuroimmunology|
|State||Published - Feb 1989|
Bibliographical noteFunding Information:
This inve;~igafion was supported by US Public Health ServiceR esearchG rant AI-13987,a nd S~U Schoolo f Medicine grant CRC-28-88.
- Adoptive transfer
- Experimental allergic encephalomyelitis
- Lymph node cell
- Proteolipid protein